Efficacy News and Research

RSS
Defective metabolism of Parkinson’s drug is linked to adverse side effects

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Researchers develop new sequencing-based approach for pathogen discovery

Researchers develop new sequencing-based approach for pathogen discovery

Covid-19 project receives government funding to expand globally

Covid-19 project receives government funding to expand globally

CytoDel successfully delivers neuronal antibody in animal models of botulism

CytoDel successfully delivers neuronal antibody in animal models of botulism

Repurposed drug can treat hearing loss in humans

Repurposed drug can treat hearing loss in humans

New approach produces strong antidotal efficacy in treating lethal botulism in animals

New approach produces strong antidotal efficacy in treating lethal botulism in animals

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

Is one-dose COVID-19 vaccination better than two?

Is one-dose COVID-19 vaccination better than two?

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Researchers use network-based approach to examine the impact of policies and vaccination strategies

Researchers use network-based approach to examine the impact of policies and vaccination strategies

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

Researchers receive £230,000 to develop world's first smart vaccine device

Researchers receive £230,000 to develop world's first smart vaccine device

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Novel drug may help treat osteoporosis, shows study

Novel drug may help treat osteoporosis, shows study

New mathematical model proposes optimal treatment strategies for COVID-19

New mathematical model proposes optimal treatment strategies for COVID-19

Researchers identify natural products with potential to disrupt viral spread

Researchers identify natural products with potential to disrupt viral spread

COVID-19 vaccination in UK may not lead to relaxation of control measures

COVID-19 vaccination in UK may not lead to relaxation of control measures

Mid-term clinical trial results of two cell therapies for critical limb ischemia show similar outcomes

Mid-term clinical trial results of two cell therapies for critical limb ischemia show similar outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.